Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $198K 800 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $198K 800 sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $157K 640 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $193K 560 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nonko EugeneDirector |  MAXMediaAlpha, Inc.Open-market sale · 10b5-1 plan | SELL | $224K 15.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 6 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $198K 634 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Marinaro MichaelPresident |  MDTMedtronic plcGrant or award | A | — 43.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Winitzer OriDirector |  LCIDLucid Group, Inc.Open-market sale · 10b5-1 plan | SELL | $3,090 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 5 | Marinaro MichaelPresident | MDTMedtronic plc Grant or award | A | — 16.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 5 | de Verneuil VaninaEVP, General Counsel, Corp Sec |  VIRVir Biotechnology, Inc.Open-market sale · 10b5-1 plan | SELL | $15K 1,343 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Clark Benjamin M.EVP - Global Supply Chain |  ECLECOLAB INC.Option exercise | M | — 8,843 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Benton Kelly WVP & CAO |  SAIASAIA INCTax withholding | F | $46K 129 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Option exercise · 10b5-1 plan | M | $567K 47.2K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $23K 8,334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $155K 40.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $25K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $50K 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $39K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $5,943 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Felice Laura L.EVP, Chief Financial Officer |  BJBJ's Wholesale Club Holdings, Inc.Option exercise · 10b5-1 plan | M | — 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 87 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 586 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 219 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 397 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 389 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 341 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 165 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 198 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 83 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | — 856 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | $146K 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 2 | Kane CharlesDirector |  SYMSymbotic Inc.Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |